Skip to main navigation
AC Immune - World-class science that makes a difference in  patients' lives
  • About Us
    About us Our Teams Our Partners Our R&D Strategy
  • Our Science
    Our Science Pioneering Precision Medicine Technology Platforms Scientific Publications
  • Our Pipeline
    Our Pipeline Therapeutic Focus Clinical Trials
  • Investors
  • Careers
    Careers Join us
Investors
  • Why Invest
  • Key Figures
  • Share Price
  • Analyst Coverage
  • Milestones
  • FAQ
  • Contacts & Resources
Press Releases
In the News
Events & Presentations
Corporate Governance
Financial Reporting
Annual Reports
search

Event Details

  1. Home
  2. Investors
  3. events
  4. event details
  5. AD/PD™ 2024 Symposium - State-of-the-art of treatment and diagnosis of alpha-synuclein pathologies

AD/PD™ 2024 Symposium

Mar 6, 2024 from 8:40 AM to 10:40 AM WET

State-of-the-art of treatment and
diagnosis of alpha-synuclein pathologies

Use the link at the bottom to view the replay.

2024_ADPD Industry symposium_1

 

2024_ADPD Industry symposium_2

 

Click here for webcast

Supporting Materials

AD/PD™ 2024 Symposium - Slide deck 12.7 MB

Shareholder Tools

Print Page
Print Page
Email Alerts
Email Alerts
Information Request
Information Request
Contact IR
Contact IR

AC Immune SA

EPFL Innovation Park-Building B 1015 Lausanne / Switzerland
  • Phone: +41 21 345 91 21
  • Fax: +41 21 345 91 20
  • Email: info@acimmune.com
  • Home
  • About Us
  • Our Science
  • Our Pipeline
  • Investors
  • Careers

Stay in touch

Get to know us

Social Links (Redesign)

© 2026 AC Immune SA

Legal Links (Redesign)

  • Privacy policy
  • Supplier information
  • Terms of use